Kidney function estimated from serum creatinine and cystatin C and peripheral arterial disease in NHANES 1999-2002

European Heart Journal

Volumn 30, Issue 15, 2009, Pages 1918-1925

  Selvin, Elizabeth ^a,b   Köttgen, Anna ^a   Coresh, Josef ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic kidney disease; Cystatin C; Epidemiology; Glomerular filtration rate; NHANES; Peripheral arterial disease

Indexed keywords

CREATININE; CYSTATIN C;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORONARY BLOOD VESSEL; CREATININE BLOOD LEVEL; DISEASE MARKER; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; ANKLE BRACHIAL INDEX; BIOLOGICAL MARKERS; CONFIDENCE INTERVALS; CREATININE; CYSTATIN C; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; NUTRITION SURVEYS; PERIPHERAL VASCULAR DISEASES; PREDICTIVE VALUE OF TESTS;

EID: 68749099648     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehp195     Document Type: Article

References (35)

1. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 2003; 42:1050-1065.
2. Weiner DE, Tighiouart H, Amin MG, Stark PC, Macleod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004; 15:1307-1315.
3. Landray MJ, Thambyrajah J, McGlynn FJ, Jones HJ, Baigent C, Kendall MJ, Townend JN, Wheeler DC. Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment. Am J Kidney Dis 2001; 38:537-546.
4. O'Hare A, Johansen K Lower-extremity peripheral arterial disease among patients with end-stage renal disease. J Am Soc Nephrol 2001; 12:2838-2847.
5. Luscher TF, Creager MA, Beckman JA, Cosentino F. Diabetes and vascular disease: pat ho physio logy, clinical consequences, and medical therapy: part II. Circulation 2003; 108:1655-1661.
6. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1-S266.
7. Wattanakit K, Folsom AR, Selvin E, Coresh J, Hirsch AT, Weatherley BD. Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) Study. J Am Soc Nephrol 2007; 18:629-636.
8. O'Hare AM, Glidden DV, Fox CS, Hsu Cy. High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the National Health and Nutrition Examination Survey 1999-2000. Circulation 2004; 109:320-323.
9. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004; 110:738-743.
10. Laterza OF, Price CP, Scott MG. Cystatin C: an improved estimator of glomerular filtration rate? Clin Chem 2002; 48:699-707.
11. Newman DJ. Cystatin C: what more do we need to know? Nephron Clin Pract 2003; 93:c122-c123.
12. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002; 40:221-226.
13. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function - measured and estimated glomerular filtration rate. N Engl J Med 2006; 354:2473-2483.
14. Madero M, Sarnak MJ, Stevens LA. Serum cystatin C as a marker of glomerular filtration rate. Curr Opin Nephrol Hypertens 2006; 15:610-616.
15. Survey Operations Manuals, Brochures, and Consent Documents: 1999-current NHANES. National Center for Health Statistics, Centers for Disease Control; 2007. http://www.cdc.gov/nchs/about/major/nhanes/currentnhanes. htm.
16. Kottgen A, Selvin E, Stevens LA, Levey AS, Van Lente F, Coresh J. Serum cystatin C in the United States: The Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 2008; 51:385-394.
17. Lijmer JG, Hunink MG, van den Dungen JJ, Loonstra J, Smit AJ. ROC analysis of noninvasive tests for peripheral arterial disease. Ultrasound Med Biol 1996; 22: 391-398.
18. Feigelson HS, Criqui MH, Fronek A, Langer RD, Molgaard CA. Screening for peripheral arterial disease: the sensitivity, specificity, and predictive value of non-invasive tests in a defined population. Am J Epidemiol 1994; 140:526-534.
19. NHANES 2001-2002 Public Release Data File: Laboratory 40 - Standard Biochemistry Profile. National Center for Health Statistics, Centers for Disease Control; 2007. http://www.cdc.gov/nchs/data/nhanes/nhanes-01-02/140-b- doc.pdf.
20. NHANES 1999-2000 Laboratory Procedure Manual: Creatinine. National Center for Health Statistics, Centers for Disease Control; 2007. http://www.cdc.gov/nchs/data/nhanes/frequency/lab18doc.pdf.
21. Selvin E, Manzi J, Stevens LA, Van LF, Lacher DA, Levey AS, Coresh J. Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis 2007; 50:918-926.
22. Newman DJ. Cystatin C. Ann Clin Biochem 2002; 39:89-104.
23. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, forthe Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomer-ular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130:461-470.
24. Levey AS, Coresh J, Greene T, Stevens LA, Zhang Y, Hendriksen S, Kusek JW, Van Lente F, for the Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254.
25. Stevens LA, Coresh J, Schmid CH, Feldman HI, Froissart M, Kusek J, Rossert J, Van Lente F, Bruce RD III, Zhang Y, Greene T, Levey AS. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 2008; 51:395-406.
26. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G. National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139:137-147.
27. Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, Seliger SL, Kestenbaum B, Psaty B, Tracy RP, Siscovick DS. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med 2006; 145:237-246.
28. Lohr SL. Sampling Design and Analysis. Pacific Grove, CA: Duxbury Press; 1999.
29. National Center for Health Statistics: National Health and Nutrition Examination Survey (NHANES) Analytic Guidelines, http://www.cdc.gov/nchs/about/ major/nhanes/nhanes2003-2004/analytical-guidelines.htm (9 May 2007).
30. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 2002; 106:3143.
31. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA 2003; 289: 2560-2571.
32. Arpegard J, Ostergren J, de Faire U, Hansson LO, Svensson P. Cystatin C - a marker of peripheral atherosclerotic disease? Atherosclerosis 2008; 199:397-401.
33. O'Hare AM, Newman AB, Katz R, Fried LF, Stehman-Breen CO, Seliger SL, Siscovick DS, Shlipak MG. Cystatin C and incident peripheral arterial disease events in the elderly: results from the Cardiovascular Health Study. Arch Intern Med 2005; 165:2666-2670.
34. Menon V, Shlipak MG, Wang X, Coresh J, Greene T, Stevens L, Kusek JW, Beck GJ, Collins AJ, Levey AS, Sarnak MJ. Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med 2007; 147:19-27.
35. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C. Cystatin C and the Risk of death and cardiovascular events among elderly persons. N Engl J Med 2005; 352:2049-2060.